欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/1508/002
药品名称Human Albumin CSL Behring
活性成分
    • albumin human 20.0 %
剂型Solution for infusion
上市许可持有人CSL Behring GmbH Emil-von-Behring-Strasse 76 35041 Marburg Germany
参考成员国 - 产品名称Denmark (DK)
互认成员国 - 产品名称
    • Belgium (BE)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Germany (DE)
      Alburex 20
    • Netherlands (NL)
      Alburex 20, 200 g/l, oplossing voor infusie
    • France (FR)
    • Spain (ES)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Alburex 20
    • Hungary (HU)
      ALBUREX 200 g/l oldatos infúzió
    • Bulgaria (BG)
    • Cyprus (CY)
      ALBUREX 20 SOLUTION FOR INFUSION
    • Czechia (CZ)
      Alburex 20
    • Romania (RO)
      Alburex 200 g/l solutie perfuzabila
    • Slovenia (SI)
    • Slovakia (SK)
      Alburex 20
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
    • Sweden (SE)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Malta (MT)
许可日期2016/05/04
最近更新日期2024/04/23
药物ATC编码
    • B05AA01 albumin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Biological: Blood Product
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase